Diagnostics News and Research

RSS

General Electric extends healthcare IT portfolio to mobile devices and tablet computing

General Electric, an industry leader in the adoption of mobile technology, demonstrated the extension of its healthcare IT portfolio to mobile devices and tablet computing at this week's Health Information Management and Systems Society (HIMSS) Conference in Orlando.

24 Feb 2011

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

Cell Signaling Technology, Inc. of Danvers, MA announced today a joint commercialization partnership with Astellas Pharma, Inc. of Tokyo, Japan focused on the delivery of personalized cancer therapeutics and diagnostics.

From Cell Signaling Technology 24 Feb 2011

FDA clears Agendia's breast cancer recurrence assay

Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration clearance for MammaPrint, its widely used breast cancer recurrence assay.

23 Feb 2011

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

Dual lab tests accurately predict vein graft blood clots in patients during CABG

A team of heart experts at Johns Hopkins has found that dual lab tests of blood clotting factors accurately predict the patients whose blood vessels, in particular veins implanted to restore blood flow to the heart during coronary artery bypass grafting, are more likely to fail or become clogged within six months.

23 Feb 2011

GE Healthcare IT introduces eHealth Community Desktop solution

GE Healthcare IT, a leading provider of health information technologies, today announced its eHealth Community Desktop, an open standards framework for delivering clinical applications built on top of a connected healthcare community. Its foundation is a portal technology that provides Clinicians and other providers across the healthcare continuum a web-based, simple and easy way to view patient data available within a Health Information Exchange (HIE).

23 Feb 2011

Researchers discover biological pathway that alters normal cells into aggressive tumors

A biological pathway that transforms normal cells into aggressive tumors has been discovered by researchers at Cleveland Clinic's Lerner Research Institute.

23 Feb 2011

Caliper Life Sciences, IntegenX enter license agreement for microfluidics patent portfolio

IntegenX Inc. and Caliper Life Sciences, Inc. today announced a license agreement providing IntegenX access to Caliper's microfluidics patent portfolio.

23 Feb 2011

Biomoda completes sample collection in pilot study of CyPath diagnostic assay for lung cancer

Cancer diagnostics company Biomoda, Inc. today announced that it has completed patient enrollment and sample collection for the pilot study to determine the clinical sensitivity and specificity of its CyPath® diagnostic assay for the early detection of lung cancer.

23 Feb 2011

Phoenix, Uniontown sign three year agreement for comprehensive IT infrastructure outsourcing services

Phoenix Health Systems, a premier provider of integrated information technology outsourcing and consulting services for healthcare organizations, announced today that Uniontown Hospital, Uniontown, PA, has signed a three year agreement with Phoenix for comprehensive IT infrastructure outsourcing services.

23 Feb 2011

NanoString launches fixed-panel assay product for human molecular karyotyping

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.

From NanoString Technologies 22 Feb 2011

Why are Chlamydia and HPV major public health problems?

Chlamydia trachomatis is a bacterium that is one of the most common sexually transmitted infections in Europe. Rates in sexually active young people are commonly between 5% and 10%. The number of diagnosed cases is increasing in many European countries, in part due to increased testing and the use of more sensitive tests.

22 Feb 2011

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

MedTrust Online and Avantra Biosciences announced today a novel collaboration to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences' revolutionary QPDx multiplex immunoassay system.

22 Feb 2011

GE Healthcare, CDC collaborate to explore efficacy of actionable health alerts

After a full year of feasibility studies, the Centers for Disease Control and Prevention is taking a significant step toward providing public health information at the point-of-care. CDC is collaborating with GE Healthcare, a unit of General Electric Company, to explore the efficacy of actionable health alerts, delivered instantly to a physician's electronic medical record.

21 Feb 2011

GE Healthcare announces two new EMR solutions certified for meaningful use at HIMSS meeting

At the annual meeting of the Health Information Management and Systems Society in Orlando this week, GE Healthcare announced two new Electronic Medical Record solutions that have been certified for meaningful use.

21 Feb 2011

GE Healthcare completes Orbotech Medical acquisition

GE Healthcare, a unit of General Electric Company, announced that it has completed the acquisition of the assets of Orbotech Medical Solutions Ltd. (OMS), a subsidiary of Orbotech Ltd. (Orbotech), and a manufacturer of cadmium zinc telluride (CZT) detectors used in GE Healthcare's innovative Alcyone nuclear medicine technology.

21 Feb 2011

GE Centricity Enterprise v6.9 achieves Complete EHR ONC-ATCB 2011/2012 certification

GE Healthcare is pleased to announce that GE Centricity Enterprise version 6.9 is officially 2011/2012 compliant and was certified as a Complete EHR February 17, 2011 by Drummond Group Inc. Drummond Group made the designation in its capacity as an Office of the National Coordinator - Authorized Temporary Certification Body (ONC-ATCB) in accordance with the applicable Eligible Hospital certification criteria adopted by the U.S. Secretary of Health and Human Services (HHS).

21 Feb 2011

New blood pressure measurement device may enable doctors to treat patients more effectively

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients' blood pressure is measured.

20 Feb 2011

CompanDX, CRL enter multi-year agreement to develop biomarker panels

CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year agreement to collaborate in the development and support of biomarker panels and companion diagnostic development for pharmaceutical, biotech and academic clients worldwide.

19 Feb 2011

Predictive to present results on development of real-time multiplexed PCR FGFR3 assay at ASCO 2011

Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.

19 Feb 2011

Diagnostics News and Research

General Electric extends healthcare IT portfolio to mobile devices and tablet computing

CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products

FDA clears Agendia's breast cancer recurrence assay

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

Dual lab tests accurately predict vein graft blood clots in patients during CABG

GE Healthcare IT introduces eHealth Community Desktop solution

Researchers discover biological pathway that alters normal cells into aggressive tumors

Caliper Life Sciences, IntegenX enter license agreement for microfluidics patent portfolio

Biomoda completes sample collection in pilot study of CyPath diagnostic assay for lung cancer

Phoenix, Uniontown sign three year agreement for comprehensive IT infrastructure outsourcing services

NanoString launches fixed-panel assay product for human molecular karyotyping

Why are Chlamydia and HPV major public health problems?

MedTrust, Avantra collaborate to develop molecular diagnostic assay for cancer care

GE Healthcare, CDC collaborate to explore efficacy of actionable health alerts

GE Healthcare announces two new EMR solutions certified for meaningful use at HIMSS meeting

GE Healthcare completes Orbotech Medical acquisition

GE Centricity Enterprise v6.9 achieves Complete EHR ONC-ATCB 2011/2012 certification

New blood pressure measurement device may enable doctors to treat patients more effectively

CompanDX, CRL enter multi-year agreement to develop biomarker panels

Predictive to present results on development of real-time multiplexed PCR FGFR3 assay at ASCO 2011

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News